The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression
Open accessAbstract
Selective serotonin reuptake inhibitors (SSRIs) are a first-line treatment for depression. They have been reported to regulate serotonin signalling in bone cells and may influence bone metabolism. This study aimed to investigate the effect of SSRIs on bone mineral density (BMD) in a sample of women with a lifetime history of depression. In this community-based study of 607 women, a history of depression was ascertained using the structured clinical interview for Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV-TR research version, non-patient edition. BMD was measured at the posterior-anterior (PA) spine, hip, total body and forearm using dual energy absorptiometry, and medication use and lifestyle factors were self-reported. Among 177 women with a lifetime history of depression, current users of bisphosphonates, glucocorticoids, hormone therapy and antidepressants other than SSRIs were excluded. Of the remaining 128 (median age 51.5 years, range 30-74), 26 (20.3%) reported current SSRI use. After controlling for age, weight, height and smoking history, BMD among SSRI users was 5.6% lower at the femoral neck (P=0.03), 6.2% lower at the trochanter (P=0.04) and 4.4% lower at the mid-forearm (P=0.03) than nonusers. No differences in BMD were detected at other sites. Although the mechanism remains unclear, these observations are consistent with a role for the serotonergic system in regulating bone metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some anticonvulsants, antidepressants, and antipsychotics may decrease bone mineral density and increase the risk of fracture in high‐risk patients.874, 875”
In the citing paper
“SSRI use has also been associated with low bone mineral density [92,93], as well as an increased risk of fractures [94] and hyponatremia [95].”
From Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014) · cites this paper as [93]
Citations
Cites
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
A physical activity questionnaire for the elderly
VOORRIPS, L. E., RAVELLI, A. C. J., DONGELMANS, P. C. A., DEURENBERG, P., & VAN STAVEREN, W. A. (1991) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199108000-00015 · Cited by 902
Central Nervous System–Active Medications and Risk for Falls in Older Women
Ensrud, K. E., Blackwell, T. L., Mangione, C. M., Bowman, P. J., Whooley, M. A., Bauer, D. C., Schwartz, A. V., Hanlon, J. T., Nevitt, M. C., & For The Study of Osteoporotic Fractures Research Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50453.x · Cited by 620
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
Bone Mineral Density in Women with Depression
Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., & Gold, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351602 · Cited by 471
Liu, B., Anderson, G., Mittmann, N., To, T., Axcell, T., & Shear, N. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09528-7 · Cited by 388
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
Richards, J. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.188 · Cited by 386
Depression, Falls, and Risk of Fracture in Older Women
Whooley, M. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.484 · Cited by 343
Diem, S. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1240 · Cited by 326
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Haney, E. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1246 · Cited by 286
Central Nervous System Active Medications and Risk for Fractures in Older Women
Ensrud, K. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.949 · Cited by 277
Factors associated with the lumbar spine and proximal femur bone mineral density in older men
Cauley, J. A., Fullman, R. L., Stone, K. L., Zmuda, J. M., Bauer, D. C., Barrett-Connor, E., Ensrud, K., Lau, E. M. C., Orwoll, E. S., & For the Mr. OS Research Group (2005) · Osteoporosis International · doi:10.1007/s00198-005-1866-8 · Cited by 258
Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth
Warden, S. J., Robling, A. G., Sanders, M. S., Bliziotes, M. M., & Turner, C. H. (2005) · Endocrinology · doi:10.1210/en.2004-1259 · Cited by 221
Acute phase proteins in major depression
Berk, M., Wadee, A. A., Kuschke, R. H., & O'Neill-Kerr, A. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00139-6 · Cited by 215
Self-citationBliziotes, M. M., Eshleman, A. J., Zhang, X.-W., & Wiren, K. M. (2001) · Bone · doi:10.1016/s8756-3282(01)00593-2 · Cited by 215
Serotonin Regulates Osteoclast Differentiation Through Its Transporter
Battaglino, R., Fu, J., Späte, U., Ersoy, U., Joe, M., Sedaghat, L., & Stashenko, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040606 · Cited by 213
Expression of Serotonin Receptors in Bone
Westbroek, I., van der Plas, A., de Rooij, K. E., Klein-Nulend, J., & Nijweide, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101824200 · Cited by 206
Hubbard, R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg114 · Cited by 197
Bone mineral density in subjects using central nervous system-active medications
Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.033 · Cited by 191
Serotonin and fluoxetine modulate bone cell function in vitro
Gustafsson, B. I., Thommesen, L., Stunes, A. K., Tømmerås, K. A., Westbroek, I., Waldum, H. L., Slørdahl, K., Tamburstuen, M. V., Reseland, J. E., & Syversen, U. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20734 · Cited by 175
Prevalence of Osteoporosis in Australian Women
Henry, M. J., Pasco, J. A., Nicholson, G. C., Seeman, E., & Kotowicz, M. A. (2000) · Journal of Clinical Densitometry · doi:10.1385/jcd:3:3:261 · Cited by 137
Self-citationBone mineral density in premenopausal women with major depressive disorder
Yazıcı, K. M., Akıncı, A., Sütçü, A., & Özçakar, L. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00017-9 · Cited by 84
Jacka, F. N., Pasco, J. A., Henry, M. J., Kotowicz, M. A., Dodd, S., Nicholson, G. C., & Berk, M. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200512010-00015 · Cited by 84
Self-citationNeural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine)
Warden, S. J., Bliziotes, M. M., Wiren, K. M., Eshleman, A. J., & Turner, C. H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.06.005 · Cited by 83
Gustafsson, B. I., Westbroek, I., Waarsing, J. H., Waldum, H. L., Solligård, E., Brunsvik, A., Dimmen, S., van Leeuwen, J. P. T. M., Weinans, H., & Syversen, U. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20733 · Cited by 68
Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromsø Study
Søgaard, A. J., Joakimsen, R. M., Tverdal, A., Fønnebø, V. M., Magnus, J. H., & Berntsen, G. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1784-1 · Cited by 56
Research works printed but not linked: 2
- Gustafsson, 2005, J Bone Miner Res, 20, S113
- Jacka, 2007, JMHG, 4, 292
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“SSRI use has also been associated with low bone mineral density [92,93], as well as an increased risk of fractures [94] and hyponatremia [95].”
BackgroundFactors Influencing Early Dental Implant Failures
Chrcanovic, B. R., Kisch, J., Albrektsson, T., & Wennerberg, A. (2016) · Journal of Dental Research · doi:10.1177/0022034516646098 · Cited by 286
Cohort Profile: Geelong Osteoporosis Study
Pasco, J. A., Nicholson, G. C., & Kotowicz, M. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr148 · Cited by 262
Self-citation
Metadata
- Authors
- Williams, L. J., Henry, M. J., Berk, M., Dodd, S., Jacka, F. N., Kotowicz, M. A., Nicholson, G. C., & Pasco, J. A.
- Affiliations
- Barwon Health (AU)
- Corresponding author
- Williams, Lana J.
- ORCID
- Venue
- International Clinical Psychopharmacology
- Published
- 2008-03
- Volume
- 23
- Issue
- 2
- Pages
- 84-87
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2006374111
- Cited by
- 117
- References
- 27
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 3 · 2015: 9 · 2014: 7 · 2013: 10 · 2012: 14
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- selective serotonin reuptake inhibitors, bone mineral density, depression, women, serotonergic system, bone metabolism, antidepressant side effects, femoral neck, trochanter, osteoporosis
- MeSH terms
- Adult, Aged, Depressive Disorder, Female, Health Status, Humans, Middle Aged, Exercise, Bone Density, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.